BERLIN (Reuters) - German pharmaceuticals group Bayer keeps benefiting from the weak euro, though the region's deepening debt crisis is beginning to weigh on orders in some sectors, a Swiss newspaper reported, citing the group's chief financial officer. "As positive as the situation looks at the moment, it is clear that this will not be the case for the long term," Finanz und Wirtschaft quoted Werner Bauer as saying. "We are noticing more cautious orders in several upstream industries" as consumers are growing cautious amid the financial crisis, he said. ...
via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment